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CLINICAL PROTEOMICS IN ASSESSMENT OF THE PLACENTA
I.A. Buhimschi and Catalin S. Buhimschi. Department of Obstetrics, Gynecology and
Reproductive Sciences, Yale University School of Medicine, New Haven, Connecticut,
USA
Proteomics is the study of expressed proteins which emerged to complement genomic re-
search. The major advantage of proteomics is it investigates directly the functional mol-
ecules (proteins), not the source code. Proteomics holds the promise of providing more
direct insight into true mechanisms of human diseases. Because placenta is a key patho-
physiological participant in several major obstetrical syndromes such as preterm labor
and preeclampsia (PE), identification of relevant biomarkers can profoundly impact on
prediction of fetal outcome and treatment efficacy. For the last several years our group
pioneered a complex series of experiments aimed to better understand the pathophysiol-
ogy of preterm labor and PE.
We first concentrated in understanding the relationships between histological chorioam-
nionitis, funisitis and presence in amniotic fluid of proteomic biomarkers characteristic of
inflammation (DEFENSIN-1 and -2, and CALGRANULIN C and A). Amniotic fluid pro-
files were generated from 139 women with singleton pregnancies admitted with signs or
symptoms of preterm birth and enrolled prospectively. Proteomic analysis of the amniotic
fluid provides an opportunity for early recognition of histological chorioamnionitis and
targeted treatment of the fetus, in utero, prior to clinical manifestation of the disease.
We further performed comprehensive proteomics profiling of the urine of women with
hypertensive disorders during pregnancy (n¼272), including women with severe or super-
imposed PE. We found that a panel of proteomic biomarkers, non-random fragments of
SERPINA-1 and ALBUMIN, can accurately predict and diagnose PE and discriminate
this condition from other hypertensive proteinuric diseases in pregnancy. De-novo se-
quencing in MS/MS mode followed by validation experiments in the urine and placenta
identified presence and localization of the biomarkers. In the placenta SERPINA-1 was
sequestered within the fetal space. Our results provided insight into a novel pathological
mechanism of PE which may offer new therapeutic opportunities in the future.
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Chemokines play a key role during inflammatory reactions, driving the leukocyte recruit-
ment process through the activation of specific 7-TM receptors. A set of chemokine re-
ceptors structurally unable to elicit conventional signalling responses and cell migration
after ligand engagement has also been described. These ’silent’ (i.e. non-signalling) che-
mokine receptors include D6, a high affinity receptor for inflammatory CC chemokines
that cycles constitutively and targets the ligand to degradation. D6 is mainly expressed
by lymphatic endothelial cells in several tissues, and in vivo evidence demonstrates its
non-redundant role in the control of the local inflammatory response. In this study we
demonstrated that D6 is also expressed on invading extravillous trophoblasts and on
the apical side of syncytiotrophoblast cells, at the very interface between maternal blood
and fetus. In vitro experiments using trophoblast cell lines indicate that D6 does not sup-
port chemokine transcytosis and efficiently removes inflammatory chemokines from the
milieu. The role of placental D6 was investigated in two different models of inflamma-
tion-driven abortion. When compared with WT littermates, pregnant D6-/- mice exposed
to LPS or antiphospholipid autoantibodies showed higher levels of inflammatory CC che-
mokines and increased leukocyte infiltrate in placenta. This exacerbated inflammatory re-
actions caused an increased fetal loss rate in D6-/-, which could be reverted in animals
treated with a combination of anti inflammatory CC chemokine monoclonal antibodies.
Thus, D6 is a chemokine scavenger receptor strategically located at the fetalematernal
interface to dampen placental inflammation. The chemokine system is a prime target
for the development of new therapeutic strategies for diverse disorders. This evidence rai-
ses the possibility that blocking strategies targeting inflammatory CC chemokines may
also be effective in fetal loss prevention.P23
PROFILING TOTAL AND ALLELE-SPECIFIC DNA METHYLATION IN HU-
MAN PLACENTAS
K. Kerkel, L. Jiang, E. Yuan, A. Spadola, M. Morris, V. Haghighi and B. Tycko.
Columbia University Medical Center, New York, NY, USA
Objectives: Epigenetic regulation of gene dosage is documented as a mechanism of con-
trolling placental and fetal growth. For example, the phenotypes of mice under- or over-
expressing imprinted genes and molecular data from human syndromes of overgrowth
and growth restriction show that a major role of imprinted genes is to act as feto-placental
growth rheostats. Understanding the full extent of epigenetic regulation in human pla-
centa will be important for a complete understanding of intrauterine growth restriction.
We have developed a new approach, called methylation-sensitive SNP array analysis
(MSNP), for profiling net DNA methylation and allele-specific DNA methylation
(ASM) in human tissues.
Methods: MSNP is a simple adaptation of Affymetrix SNP arrays for profiling DNA
methylation; we have profiled DNA methylation at 40K informative markers (SNP-
tagged loci) distributed across the human genome, assessing patterns of net and allele-
specific DNA methylation in human placentas, peripheral blood leukocytes (PBL),
fibroblasts and several types of tumors, including acute myeloid leukemias and complete
hydatidiform moles.
Results: The MSNP method has revealed tissue-specific patterns of net DNA methyla-
tion, which clearly distinguish normal placenta and hydatidiform moles from non-placen-
tal tissues, and has also uncovered new examples of loci with ASM, some showing ASM
in placenta but not in PBL, and others showing the opposite pattern. We are currently as-
sessing these loci for whether the ASM is imprinted or non-imprinted. For the loci with
non-imprinted ASM we are asking whether the allelic asymmetry may depend on the lo-
cal DNA sequence.
Conclusions: MSNP is an effective method for profiling net and allele-specific DNA
methylation in human tissues. This approach is beginning to reveal clear differences in
epigenetic marks in human placenta compared to other human tissues, and is also uncov-
ering novel examples of loci with ASM, some of which are imprinted and others non-im-
printed. Data from MSNP will lead to a more complete understanding of the role of DNA
methylation in human placental biology.
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ACCUMULATION OF MACROPHAGES IN PLACENTA AND ADIPOSE TISSUE
OF OBESE WOMEN.
S. Hauguel-De Mouzon, Jean-Claude Challier, M. Guerre-Millo, T. Bintein, and J. Min-
ium. Case Western Reserve University, Department of Obstetrics and Gynecology, Metro
Health Medical Centre, Cleveland, Ohio, USA
Chronic low grade systemic inflammation is a hallmark of obesity and diabetes. We have
shown previously that expression of cytokines and markers of inflammation are increased
in placenta of obese women with GDM. The aim of this study was to examine the con-
tribution of maternal white adipose tissue and placental macrophages to the inflammatory
responses of pregnancy.
Methods: Lean (BMI<25) and obese women (BMI>30) were recruited at term elective
cesarean deliveries (390.4 weeks) with no sign of infection. Abdominal subcutaneous
adipose tissue (3-5g) was obtained at the time of laparotomy and placentas were collected
at delivery. Fragments of both tissues were embedded in paraffin for immunohistochem-
istry and snap frozen in liquid N2 for molecular assays. Macrophages were visualized by
labelling tissue sections with the macrophage markers CD68 and CD14. The macrophage
areas were quantitated from 10 labeled fields/ section using ImageJ1.30v software. The
phenotype of macrophages was characterized by flow cytometry and realtime PCR.
Results: CD68+ macrophages in adipose tissue increased from 7.7+1.1 to 66 +3.2 %
(p<0.001) in lean (BMI 21.48.8) vs. obese (BMI 35.26.2) women. The CD68+
area staining the Hofbauer placental resident macrophages also increased with maternal
adiposity (892243 to 2583247 mm2/section (p<0.001). In obese women with GDM,
the mean CD68+ area was 4.6 fold larger than in lean controls due to dramatic focal ac-
cumulation of macrophages in stem villi (p<0.05). Double staining of placental sections
showed a differential localization (peripheral vs. central) of CD14+ and CD68+ macro-
phages within the villous section. Macrophage accumulation in tissue was associated
with a 1.8, 2.4 and 1.4 increased in the expression of CD64, CD68 and EMR1 as well
as a 2.2 fold increase in TNF-alpha.
Conclusion: Obesity during pregnancy is associated with dramatic macrophage accumu-
lation in adipose tissue and placenta. The concomitant enrichment of maternal circulating
macrophages suggest that systemic macrophages represent one common source for tissue
infiltration. On-going studies are investigating the possibility that a second population of
placental macrophages multiply from pre-existing resident Hofbauer cells.
